GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (NAS:NBTX) » Definitions » Float Percentage Of Total Shares Outstanding

NBTX (Nanobiotix) Float Percentage Of Total Shares Outstanding : 85.45% (As of Dec. 11, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nanobiotix Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nanobiotix's float shares is 40.50 Mil. Nanobiotix's total shares outstanding is 47.40 Mil. Nanobiotix's float percentage of total shares outstanding is 85.45%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nanobiotix's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nanobiotix's Institutional Ownership is 14.04%.

Nanobiotix Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Nanobiotix's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=40.50/47.40
=85.45%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanobiotix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (NAS:NBTX) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XPAR:DBV XPAR:IPH XPAR:IVA XPAR:AELIS XPAR:MEDCL XPAR:GNFT XPAR:TNG XPAR:ALSEN XPAR:ADOC XPAR:OSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
0QAV:UK NANO:France 5NRA:Germany 5NR:Germany
Address
60 Rue de Wattignies, Paris, FRA, 75012
Website
https://www.nanobiotix.com
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.